ACI 13th Annual Summit on Biosimilars & Innovator Biologics
June 29, 2022

On June 29, Axinn partners Chad Landmon and Jason Murata will speak at ACI's 13th Summit on Biosimilars & Innovator Biologics being held June 28-29 in Boston.

Chad Landmon will speak on a panel entitled, "The Economics of Biosimilars: Improving Market Access, Sustainable Pricing and Reimbursement Policies.” Panelists will discuss current market dynamics for biosimilars, the implications of insurers placing biosimilars on “primary tiers," and the implications of the Lower Drug Costs Now Act.

Jason Murata will speak on a panel entitled, "Advocating for Diversity in IP: Practical Ideas for Implementing Change.” Panelists will discuss growing the awareness of pharmaceutical IP practitioners among underrepresented racial and ethnic groups, accelerating the advancement of a more diverse pharmaceutical IP community, and implementing organizational changes that promote diversity.

Click here for more information, including how to register. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.